MYCOLOGICS, INC.

Company Information
Address MYCOLOGICS, INC.
12635 E. MONTVIEW BLVD
AURORA, CO, 80045


Information

DUNS: 190042098

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Leishmania major nucleoside hydrolase inhibitors

    Amount: $101,950.00

    DESCRIPTION (provided by applicant): Leishmania are typanosomatid protozoans that are transmitted by phlebotomine sand flies causing leishmaniasis. Leishmaniasis is a zoonosis and affects 12 million p ...

    STTRPhase I2007Department of Health and Human Services
  2. A novel vaccine against Leishmania

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Leishmania are typanosomatid protozoans that are transmitted by phlebotomine sand flies causing leishmaniasis. Leishmaniasis affects 12 million people in 88 countr ...

    SBIRPhase I2005Department of Health and Human Services
  3. New drugs for the treatment of leishmaniasis

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Leishmania are typanosomatid protozoans that are transmitted by phlebotomine sand flies causing leishmaniasis. Leishmaniasis is a zoonosis and affects 12 million p ...

    SBIRPhase I2004Department of Health and Human Services
  4. A novel recombinant vaccine against Cryptococcus.

    Amount: $99,999.00

    DESCRIPTION (provided by applicant): Cryptococcus neoformans is an encapsulated pathogenic yeast that causes pulmonary infections and meningoencephalitis in humans and other animals. During the last ...

    STTRPhase I2004Department of Health and Human Services
  5. The glyoxylate cycle as a new target for antifungals

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Fungi cause a wide spectrum of disease states. The most common examples are relatively minor, localized infections of the skin and mucous membranes such as athle ...

    SBIRPhase I2003Department of Health and Human Services
  6. Antifungal drugs: Beta(1,6)-glucan synthesis inhibitors

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Fungi cause a wide spectrum of disease states. The most common examples are relatively minor, localized infections of the skin and mucous membranes such as athlete ...

    SBIRPhase I2003Department of Health and Human Services
  7. Inhibitors of transcription of fungal glucan synthase

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Perhaps the most striking difference between fungal cells and human cells is that fungal cells are encased in a wall that protects them from an osmotically and im ...

    SBIRPhase I2003Department of Health and Human Services
  8. A novel yeast vaccine against Coccidioides Immitis

    Amount: $99,997.00

    DESCRIPTION (provided by applicant): Coccidioidomycosis, also known as San Joaquin Valley Fever, is a fungal disease caused by Coccidioides immitis that is endemic in portions of Southern Arizona, cen ...

    SBIRPhase I2003Department of Health and Human Services
  9. A novel vaccine for Aspergillus fumigatus

    Amount: $99,997.00

    DESCRIPTION (provided by applicant): Aspergillus fumigatus is a ubiqutous spore-bearing fungus that causes multiple diseases in humans. These include allergic pulmonary asthma, aspergillomas, and inva ...

    SBIRPhase I2003Department of Health and Human Services
  10. A NOVEL SCREEN FOR INHIBITORS OF FUNGAL GPI-ANCHORING

    Amount: $100,000.00

    Perhaps the most striking difference between fungal cells and human cells is that fungal cells are encased in a wall that protects them from a hostile external environment. The cell wall plays a dynam ...

    SBIRPhase I2002Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government